BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23835063)

  • 1. ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours.
    Wilzén A; Krona C; Sveinbjörnsson B; Kristiansson E; Dalevi D; Øra I; De Preter K; Stallings RL; Maris J; Versteeg R; Nilsson S; Kogner P; Abel F
    Mol Cancer; 2013 Jul; 12(1):70. PubMed ID: 23835063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis.
    Fagone P; Nicoletti F; Vecchio GM; Parenti R; Magro G
    Acta Histochem; 2015 Oct; 117(8):820-3. PubMed ID: 26510683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of diffusion-weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation grades.
    Wen Y; Peng Y; Duan XM; Zhang N
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):718-724. PubMed ID: 28508462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors.
    Retrosi G; Sebire NJ; Bishay M; Kiely EM; Anderson J; De Coppi P; Resca E; Rampling D; Bier N; Mills K; Eaton S; Pierro A
    J Pediatr Surg; 2011 Jun; 46(6):1197-200. PubMed ID: 21683222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
    Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic features of peripheral neuroblastic tumors].
    Yang BF; Fu LB; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.
    Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G
    Cell Death Dis; 2014 Mar; 5(3):e1100. PubMed ID: 24603328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
    Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing identifies predisposing and fusion gene in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.
    Wu W; Xu WJ; Liu JB; Sun J; Huang YM; Lv ZB
    Math Biosci Eng; 2019 Aug; 16(6):7217-7229. PubMed ID: 31698611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
    Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
    Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
    Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients.
    Warren M; Matsuno R; Tran H; Shimada H
    Histopathology; 2018 Mar; 72(4):685-696. PubMed ID: 28986989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of delta-like gene and protein in neuroblastoma, ganglioneuroblastoma and ganglioneuroma.
    Hsiao CC; Huang CC; Sheen JM; Tai MH; Chen CM; Huang LL; Chuang JH
    Mod Pathol; 2005 May; 18(5):656-62. PubMed ID: 15605081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extra-adrenal peripheral neuroblastic tumors: A clinicopathological study of 18 cases.
    Shankaralingappa S; Patra S; Gami A; Trivedi P; Chalaliya AK
    Indian J Pathol Microbiol; 2023; 66(2):278-285. PubMed ID: 37077068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathology of peripheral neuroblastic tumors].
    Wang L; He LJ; Shimada H
    Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):283-8. PubMed ID: 22800533
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data.
    Tabyaoui I; Tahiri-Jouti N; Serhier Z; Bennani-Othmani M; Sibai H; Itri M; Benchekroun S; Zamiati S
    Diagn Pathol; 2013 Feb; 8():39. PubMed ID: 23445749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors.
    Neubauer H; Li M; Müller VR; Pabst T; Beer M
    Rofo; 2017 Jul; 189(7):640-650. PubMed ID: 28511265
    [No Abstract]   [Full Text] [Related]  

  • 18. The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo.
    Schulte JH; Pentek F; Hartmann W; Schramm A; Friedrichs N; Øra I; Koster J; Versteeg R; Kirfel J; Buettner R; Eggert A
    Int J Cancer; 2009 May; 124(10):2488-94. PubMed ID: 19142969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Oct4 expression: implications in the pathogenesis of neuroblastic tumours.
    Monferrer E; Burgos-Panadero R; Blanquer-Maceiras M; Cañete A; Navarro S; Noguera R
    BMC Cancer; 2019 Jan; 19(1):1. PubMed ID: 30606139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.
    Young CD; Nolte EC; Lewis A; Serkova NJ; Anderson SM
    Breast Cancer Res; 2008; 10(4):R70. PubMed ID: 18700973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.